NEW YORK, Sept. 27 - PerkinElmer is now one step closer to acquiring Packard BioScience after shareholders from both firms approved the deal, the companies said in a joint statement on Thursday.

The merger, announced in July and reported by GenomeWeb , still remains subject to customary closing conditions and regulatory approvals, including approval by the Federal Trade Commission.

The companies expect to tie the knot in the fourth quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.